# Neuroendocrine Tumors - Patient Reported Outcomes

> **NCT05064150** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Iowa** · enrollment: 2539 (actual)

## Conditions studied

- Neuroendocrine Tumors
- Gastroenteropancreatic Neuroendocrine Tumor
- Lung Neuroendocrine Neoplasm
- Neuroendocrine Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05064150
- **Lead sponsor:** University of Iowa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-10
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 2539 (ACTUAL)
- **Last updated:** 2025-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05064150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05064150, "Neuroendocrine Tumors - Patient Reported Outcomes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05064150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*